Immunome Inc. Uncategorized Contracts & Agreements
11 Contracts & Agreements
- Form of Ayala Pharmaceuticals, Inc. Support Agreement, dated February 5, 2024 (Filed With SEC on February 6, 2024)
- Master Sponsored Research Agreement, by and among Morphimmune, Inc., Purdue Research Foundation, and Purdue University, dated February 1, 2022, as amended by that certain... (Filed With SEC on August 8, 2023)
- Form of Lock-Up Agreement, dated June 29, 2023 (Filed With SEC on June 29, 2023)
- Form of Morphimmune, Inc. Stockholder Support Agreement, dated June 29, 2023 (Filed With SEC on June 29, 2023)
- Form of Immunome, Inc. Stockholder Support Agreement, dated June 29, 2023 (Filed With SEC on June 29, 2023)
- Letter Agreement by and between the registrant and the Whitehead Institute for Biomedical Research, dated November 17, 2022 (Filed With SEC on March 16, 2023)
- Description of Securities (Filed With SEC on March 16, 2023)
- Description of Securities (Filed With SEC on March 28, 2022)
- Engagement Letter, dated April 9, 2021, as amended on April 25, 2021, by and among Immunome, Inc. and Ladenburg Thalmann & Co. Inc (Filed With SEC on April 26, 2021)
- Description of Securities (Filed With SEC on March 25, 2021)
- Offer Letter Agreement by and between the registrant and Richard F. Fitzgerald, dated September 18, 2020 (Filed With SEC on September 24, 2020)
